Bausch Health
BHC
#4859
Rank
โ‚น203.25 B
Marketcap
โ‚น543.46
Share price
-4.22%
Change (1 day)
-14.11%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): -โ‚น307.11

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -โ‚น310.55. In 2025 the company made an earnings per share (EPS) of โ‚น40.26 an increase over its 2024 EPS that were of -โ‚น11.50.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น307.11-862.89%
2025โ‚น40.26-450%
2024-โ‚น11.50-92.59%
2023-โ‚น155.28160.89%
2022-โ‚น59.52-76.64%
2021-โ‚น254.7668.45%
2020-โ‚น151.24-68.91%
2019-โ‚น486.43-57.11%
2018-โ‚น1,134-272.22%
2017โ‚น658.59-199.29%
2016-โ‚น663.28798.7%
2015-โ‚น73.80-128.31%
2014โ‚น260.71-204.62%
2013-โ‚น249.21602.7%
2012-โ‚น35.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-โ‚น25.88-91.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น91.06-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA